Article
SMAD4 as a prognostic marker in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Apr 2005
Alazzouzi Hafid, Alhopuro Pia, Salovaara Reijo, Sammalkorpi Heli, Järvinen Heikki, Mecklin Jukka-Pekka, Hemminki Akeseli, Schwartz Simo, Aaltonen Lauri A, Arango Diego
Abstract excerpt
More than 50% of patients with Dukes C colorectal cancer have disease recurrence and die within 5 years after surgical removal of their primary tumor. It is currently not possible to distinguish patients with good and bad prognosis. SMAD4 is an important tumor suppressor gene that mediates transforming growth factor-beta superfamily signaling and is located in chromosome 18q21, a region with frequent genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
